Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/109171

In Collections

This item can be found in the following collections:

Brose, M.S.; Nutting, C.M.; Sherman, S.I.; Shong, Y.K.; Smit, J.W.A.; Reike, G.; ... ; Schlumberger, M. (2011)

Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyroid cancer

Article / Letter to editor
All authors
Brose, M.S.; Nutting, C.M.; Sherman, S.I.; Shong, Y.K.; Smit, J.W.A.; Reike, G.; Chung, J.; Kalmus, J.; Kappeler, C.; Schlumberger, M.
Date
2011-08-11
Journal
BMC Cancer
Volume
11
Pages
-
DOI
doi:10.1186/1471-2407-11-349